These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 20681586)
1. Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements. Pham TN; Watson SA; Edwards AJ; Chavda M; Clawson JS; Strohmeier M; Vogt FG Mol Pharm; 2010 Oct; 7(5):1667-91. PubMed ID: 20681586 [TBL] [Abstract][Full Text] [Related]
2. 17O solid-state NMR as a sensitive probe of hydrogen bonding in crystalline and amorphous solid forms of diflunisal. Vogt FG; Yin H; Forcino RG; Wu L Mol Pharm; 2013 Sep; 10(9):3433-46. PubMed ID: 23822557 [TBL] [Abstract][Full Text] [Related]
3. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions. Lubach JW; Hau J Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409 [TBL] [Abstract][Full Text] [Related]
4. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry. Calahan JL; Azali SC; Munson EJ; Nagapudi K Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879 [TBL] [Abstract][Full Text] [Related]
5. 2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes. Vogt FG; Strohmeier M Mol Pharm; 2012 Nov; 9(11):3357-74. PubMed ID: 23009557 [TBL] [Abstract][Full Text] [Related]
6. Structural diversity of solid dispersions of acetylsalicylic acid as seen by solid-state NMR. Policianova O; Brus J; Hruby M; Urbanova M; Zhigunov A; Kredatusova J; Kobera L Mol Pharm; 2014 Feb; 11(2):516-30. PubMed ID: 24417442 [TBL] [Abstract][Full Text] [Related]
7. Understanding API-polymer proximities in amorphous stabilized composite drug products using fluorine-carbon 2D HETCOR solid-state NMR. Abraham A; Crull G Mol Pharm; 2014 Oct; 11(10):3754-9. PubMed ID: 25152063 [TBL] [Abstract][Full Text] [Related]
8. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction. Newman A; Engers D; Bates S; Ivanisevic I; Kelly RC; Zografi G J Pharm Sci; 2008 Nov; 97(11):4840-56. PubMed ID: 18351626 [TBL] [Abstract][Full Text] [Related]
9. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings. Duong TV; Van Humbeeck J; Van den Mooter G Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715 [TBL] [Abstract][Full Text] [Related]
10. A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica. Vogt FG; Roberts-Skilton K; Kennedy-Gabb SA Pharm Res; 2013 Sep; 30(9):2315-31. PubMed ID: 23794037 [TBL] [Abstract][Full Text] [Related]
11. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR. Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281 [TBL] [Abstract][Full Text] [Related]
12. Molecular Interactions in Posaconazole Amorphous Solid Dispersions from Two-Dimensional Solid-State NMR Spectroscopy. Lu X; Huang C; Lowinger MB; Yang F; Xu W; Brown CD; Hesk D; Koynov A; Schenck L; Su Y Mol Pharm; 2019 Jun; 16(6):2579-2589. PubMed ID: 31021639 [TBL] [Abstract][Full Text] [Related]
13. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Tian Y; Jones DS; Andrews GP Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314 [TBL] [Abstract][Full Text] [Related]
15. Drug-Polymer Interactions in Acetaminophen/Hydroxypropylmethylcellulose Acetyl Succinate Amorphous Solid Dispersions Revealed by Multidimensional Multinuclear Solid-State NMR Spectroscopy. Pugliese A; Toresco M; McNamara D; Iuga D; Abraham A; Tobyn M; Hawarden LE; Blanc F Mol Pharm; 2021 Sep; 18(9):3519-3531. PubMed ID: 34375100 [TBL] [Abstract][Full Text] [Related]
16. Exploring the influence of hydrogen bond donor groups on the microstructure and intermolecular interactions of amorphous solid dispersions containing diflunisal structural analogues. Cools L; Derveaux E; Reniers F; Dehaen W; Adriaensens P; Van den Mooter G Int J Pharm; 2024 Aug; 661():124438. PubMed ID: 38972518 [TBL] [Abstract][Full Text] [Related]
17. Atomic-Level Drug Substance and Polymer Interaction in Posaconazole Amorphous Solid Dispersion from Solid-State NMR. Lu X; Li M; Huang C; Lowinger MB; Xu W; Yu L; Byrn SR; Templeton AC; Su Y Mol Pharm; 2020 Jul; 17(7):2585-2598. PubMed ID: 32401529 [TBL] [Abstract][Full Text] [Related]
18. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion. Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138 [TBL] [Abstract][Full Text] [Related]
19. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Rumondor AC; Marsac PJ; Stanford LA; Taylor LS Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917 [TBL] [Abstract][Full Text] [Related]
20. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time. Nasu M; Nemoto T; Mimura H; Sako K J Pharm Sci; 2013 Jan; 102(1):154-61. PubMed ID: 23147444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]